SUGAMMADEX MYLAN 100 mg/ml, solution for injection 10 bottles of 5 ml
Active ingredients: SUGAMMADEX, SUGAMMADEX SODIQUE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection10 bottles of 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SUGAMMADEX MYLAN 100 mg/mL, solution injectable
- Pharmaceutical form
- solution injectable
- Route of administration
- intraveineuse
- Presentation description
- 10 flacons en verre de 5 mL
- Marketing authorisation holder
- MYLAN PHARMACEUTICALS (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 11 Sept 2023
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
60822363CIP75509021CIP133400955090212Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| SUGAMMADEX SODIQUEsolution | — | SA |
| SUGAMMADEXsolution | 100 mg · 1 mL de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: SUGAMMADEX SODIQUE équivalant à SUGAMMADEX 100 mg/mL - BRIDION 100 mg/ml, solution injectable